MYC and breast cancer: However, even breast cancers that are not MYC-driven appear to rely on intact AAR pathways to drive adaptive cancer cell survival; for example, leucine deprivation in glutamine-independent luminal breast cancer cells inhibits growth via GCN2-mediated signalling [17].